Cargando…
Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
Cognitive impairment is a core feature of schizophrenia, which is predictive for functional outcomes and is, therefore, a treatment target in itself. Yet, literature on efficacy of different pharmaco-therapeutic options is inconsistent. This quantitative review provides an overview of studies that i...
Autores principales: | Sinkeviciute, Igne, Begemann, Marieke, Prikken, Merel, Oranje, Bob, Johnsen, Erik, Lei, Wan U., Hugdahl, Kenneth, Kroken, Rune A., Rau, Carina, Jacobs, Jolien D., Mattaroccia, Silvia, Sommer, Iris E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202388/ https://www.ncbi.nlm.nih.gov/pubmed/30361502 http://dx.doi.org/10.1038/s41537-018-0064-6 |
Ejemplares similares
-
O7.6. META-ANALYSIS OF EFFICACY OF COGNITIVE ENHANCERS FOR PATIENTS WITH SCHIZOPHRENIA-SPECTRUM DISORDERS
por: Sinkeviciute, Igne, et al.
Publicado: (2018) -
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013) -
Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect
por: Sinkeviciute, Igne, et al.
Publicado: (2012) -
Negative valence of hallucinatory voices as predictor of cortical glutamatergic metabolite levels in schizophrenia patients
por: Hjelmervik, Helene, et al.
Publicado: (2021) -
The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis
por: de Boer, Janna, et al.
Publicado: (2018)